Les nouveaux anticoagulants oraux directs chez le sujet âgé : point de vue de l’interniste

Springer Science and Business Media LLC - Tập 7 Số 3 - Trang 116-121 - 2015
Emmanuel Andrès1, Ott‐Heinrích Keller2, Rachel Mourot-Cottet2, Mustapha Mecili3, Khalid Serraj4, Georges Kaltenbach5, Thomas Vogel5
1Service de médecine interne, diabète et maladies métaboliques clinique médicale B, hôpital Civil, CHRU de Strasbourg, Strasbourg cedex, France
2Service de médecine interne, diabète et maladies métaboliques, clinique médicale B, CHRU de Strasbourg, Strasbourg, France
3Service de cardiologie, hôpital de Hayange-Metz, Metz, France
4Service de médecine interne, CHRU de Oujda, Oujda, Maroc
5Service de médecine interne et gériatrie, hôpital de la Robertsau, CHRU de Strasbourg, Strasbourg, France

Tóm tắt

Từ khóa


Tài liệu tham khảo

Wanat MA (2013) Novel oral anticoagulants: a review of new agents. Postgrad Med 125:103–14

Wang Y, Bajorek B (2014) New oral anticoagulants in practice: pharmacological and practical considerations. Am J Cardiovasc Drugs 14:175–89

Levy JH, Spyropoulos AC, Samama CM, Douketis J (2014) Direct Oral Anticoagulants: new drugs and new concepts. JACCC ardiovasc Interv 7:1333–51

Lafuente-Lafuente C, Pautas E, Belmin J (2013) Anticoagulation du sujet âgé: nouveautés thérapeutiques. Presse Med 42:187–96

Sardar P, Chatterjee S, Chaudhari S, Lip GY (2014) New oral anticoagulants in elderly adults: evidence from a meta-analysis of randomized trials. J Am Geriatr Soc 62:857–64

Andrès E, Mourot-Cottet R, Keller O (2015) Patients sous anticoagulationau long cours: phénotype clinique et impact des comorbidités: étude rétrospective de 417 patients. Congrès de la Société française d’hématologie, Paris, 1er au 3 avril 2015

Andrès E, Gaertner S, Mecili M, Stephan D (2012) Amélioration des pratiques dans la prise en charge des thrombophilies et/ou autres thromboses « inhabituelles »: avantages et limites d’une réunion de concertation pluridisciplinaire. Congrès de la Société nationale française de médecine interne de Clermont-Ferrand. Rev Med Interne 33: S122–S3

http://ansm.sante.fr/Dossiers/Anti-vitamine-K-AVK/Prevention-des-hemorragies-provoquees-par-les-traitements-anticoagulants-anti-vitamine-K-AVK/(offset)/0, janvier 2015

Connolly SJ, Ezekowitz MD, Yusuf S, et al (2009) Dabigatran versus warfarin in patients with atrial fibrillation. N Engl J Med 361:1139–51

Patel MR, Mahaffey KW, Garg J, et al (2011) Rivaroxaban versuswarfarin in nonvalvular atrial fibrillation. N Engl J Med 365:883–91

Granger CB, Alexander JH, McMurray JJ, et al (2011) Apixabanversus warfarin in patients with atrial fibrillation. N Engl J Med 365:981–92

Ruff CT, Giugliano RP, Antman EM, et al (2010) Evaluation of the novel factor Xa inhibitor edoxaban compared with warfarin in patients with atrial fibrillation: design and rationale for the Effectivea Nticoa Gulation with factor xA next GEneration in Atrial Fibrillation-Thrombolysis In Myocardial Infarction study 48(ENGAGE AF-TIMI 48). Am Heart J 160:635–41

EINSTEIN Investigators, Bauersachs R, Berkowitz SD, et al (2010) Oral rivaroxaban for symptomatic venous thromboembolism. N Engl J Med 363:2499–510

EINSTEIN–PE Investigators, Büller HR, Prins MH, et al (2012) Oral rivaroxaban for the treatment of symptomatic pulmonary embolism. N Engl J Med 366:1287–97

Agnelli G, Buller HR, Cohen A, et al (2013) Oral apixaban for the treatment of acute venous thromboembolism. N Engl J Med 369:799–808

Hanon O (2013) Novel oral anticoagulants and atrial fibrillation in the elderly. Geriatr Psychol Neuropsychiatr Vieil 11:34–40

Corey S, Miller BA, Sonia M, et al (2012) Meta-analysis of efficacyand safety of new oral anticoagulants (dabigatran, rivaroxaban,apixaban) versus warfarin in patients with atrial fibrillation. Am J Cardiol 110:453–60

Quélennec B, Beretz L, Paya D, et al (2013) Medication reconciliationat hospital admission: what about the potential clinical impact of unintentional discrepancies? A prospective study in a French Internal Medicine Department. Eur J Intern Med 24:530–5

Vogel T, Geny B, Kaltenbach G, Andrès E (2014) Anticoagulationde la fibrillation atriale par les nouveaux anticoagulants chez la personne âgée: les limites de l’evidence-based medicine. MedTher 20:3–14